Bruker Corporation, a Massachusetts-based scientific instruments manufacturer, reported in its quarterly SEC filing, that on April 25, 2019, the SEC informed the company that it had concluded its investigation into payments for non-employee travel expenses, financial reporting, and certain accounting practices, and that it would not pursue an enforcement action against the company. Additionally, the company reported that its board of directors concluded a previously-disclosed internal investigation into potential FCPA questions involving the practices of business partners and former employees in China. The filing did not disclose the conclusions of that internal investigation.
May 8, 2019
Bruker Corporation reports conclusion of SEC investigation
Related by Topic
New Post
One Size Fits All: DOJ’s First Department-Wide Corporate Enforcement Policy
March 13, 2026
Insight
New Post
Former owners of medical device company indicted for roles in an international laundering and bribery scheme
March 9, 2026
News Alert
SEC closes bribery investigation into Dr. Reddy’s
February 25, 2026
News Alert